What is the most appropriate next step to prevent postpartum hemorrhage (PPH) in a female who has just delivered a baby with the umbilical cord around the neck?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oxytocin Administration is the Most Appropriate Next Step

The most appropriate next step to prevent postpartum hemorrhage after delivery of a baby with a nuchal cord is administration of oxytocin 10 IU intramuscularly within 5 minutes of delivery, ideally immediately after birth of the baby. 1, 2

Why Oxytocin is the Correct Answer

The presence of an umbilical cord around the neck does not alter the standard approach to PPH prevention—oxytocin administration should proceed immediately after the baby is delivered. 1, 3

Evidence-Based Rationale

  • Oxytocin is the first-line prophylactic agent recommended by the American College of Obstetricians and Gynecologists for preventing postpartum hemorrhage, with a recommended dose of 5-10 IU given either intramuscularly or intravenously immediately after delivery. 1

  • The intramuscular route (10 IU) is specifically recommended as the preferred medication and route for prevention of PPH in low-risk vaginal deliveries. 1, 4

  • Timing is critical: Oxytocin should be administered within 5 minutes of delivery, ideally immediately after delivery of the anterior shoulder or the baby, to prevent uterine atony before it develops—delayed administration reduces effectiveness. 1, 4

  • The 2014 CNGOF/SFAR guidelines stipulate that "it is recommended to administer 5 to 10 IU of oxytocin, slow IV or intramuscular infusion, at the time of shoulder release or immediate postpartum so as to reduce incidence of postpartum haemorrhage." 2

Why the Other Options Are Incorrect

Uterine Massage (Option A)

  • Routine uterine massage after delivery is not systematically recommended for PPH prevention and is not evidence-based as part of active management. 5, 6
  • While uterine massage is part of PPH treatment once bleeding occurs, it is not the primary preventive intervention. 5

Cord Clamping (Option B)

  • The timing of cord clamping has no significant effect on reducing PPH or severe PPH. 6
  • A 2012 WHO trial and the 2013 TRACOR trial demonstrated that controlled cord traction is not associated with a significant reduction in postpartum blood loss or risk of severe PPH. 6
  • Delayed cord clamping (60 seconds to 3 minutes) is actually recommended for neonatal benefits, not maternal PPH prevention. 3, 4

Active Management of Third Stage

  • Prophylactic oxytocin administration is the cornerstone intervention and provides the greatest reduction in PPH risk (relative risk 0.38 for PPH with active management versus expectant management). 1

  • After 50 years of research, it has become clear that prophylactic oxytocin is the most important and the only evidence-based component of active management of the third stage of labor. 6

  • Oxytocin reduces PPH-1 rates (blood loss ≥500 mL) from 5.5% to 2.6% (RR: 0.49; 95% CI: 0.27-0.88) and reduces blood loss by approximately 45 mL compared to no prophylaxis. 7

Clinical Implementation

  • Administer oxytocin 10 IU intramuscularly immediately after delivery of the baby—this can be given after delivery of the anterior shoulder or immediately postpartum. 1, 4

  • Alternative route: Intravenous infusion of oxytocin (20 to 40 IU in 1000 mL at 150 mL per hour) is an acceptable alternative, or an IV bolus of 5-10 IU given over 1-2 minutes. 4, 8

  • The nuchal cord should be managed by slipping it over the baby's head if loose, or clamping and cutting if tight, but this does not delay oxytocin administration for PPH prevention. 3

References

Guideline

Prevention of Postpartum Hemorrhage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Loose Nuchal Cord During Delivery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2009

Related Questions

What is the most appropriate next step to prevent postpartum hemorrhage (PPH) in a patient who just delivered a baby with the umbilical cord (UC) around the neck?
What are the management steps for postpartum hemorrhage (PPH) based on the 4 Ts: tone, tissue, trauma, and thrombin?
What is the most appropriate next step to prevent postpartum hemorrhage (PPH) in a female of childbearing age with no pre-existing conditions, delivering a baby with the umbilical cord around the neck?
What is the most appropriate next step to prevent postpartum hemorrhage (PPH) in a patient with a baby delivered with the umbilical cord (UC) around the neck?
What are the different drugs used for postpartum hemorrhage (PPH) management?
In which patients with cholelithiasis (gallstones) is scheduled surgery recommended?
What is the best course of action for an asymptomatic patient with thrombocytopenia and normal CBC parameters, and should a specialist referral be considered?
What is the plan of care for an adult or elderly patient with a persistent sore on the tongue that won't heal, possibly with a history of smoking or underlying conditions such as diabetes?
What are the comparative risks of Reblozyl (luspatercept) versus erythropoiesis-stimulating agent (ESA) for an adult patient with beta thalassemia and a history of transfusions?
What is the appropriate treatment for an adult patient with hyperthyrotropinemia (elevated Thyroid-Stimulating Hormone (TSH) level) of 12 mU/L, potentially with a history of thyroid disease or autoimmune disorders?
What is the appropriate management for a patient found to have rare spindle cell fragments, considering potential malignancy and varying health backgrounds?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.